Author: Editorial
-
Promis reports first human evidence of aβ oligomer reduction by pmn310
PMN310 demonstrates dose-dependent reduction of amyloid-beta oligomers in human CSF, marking a key milestone in Alzheimer’s treatment development.
-
Navigating the Risks and Rewards of Biomarker-Based Surrogates and Accelerated Approval
The risks and rewards of biomarker-based surrogates are crucial for optimizing clinical trial outcomes and guiding effective treatments.
-
Urologic Health secures $11 million for non-invasive bladder monitoring
Urologic Health raises $11million seed funding to advance a catheter-free bladder monitoring platform toward FDA clearance and US market entry.
-
Novo Nordisk’s denecimig cuts bleeding in hemophilia A regardless of inhibitors
Phase III trial shows once‑monthly and once‑weekly denecimig (Mim8) significantly reduces annualized bleeding rate versus standard care, with up to 95% of patients bleed‑free.
-
From gut resets to microbiome rejuvenation: DDW 2026 highlights transformative approaches to digestive health
An endoscopic procedure that maintains weight loss after stopping GLP-1 drugs, the double hit of stress and late-night eating on gut health, rising rectal cancer deaths in millennials, and youthful microbiome transplants that prevent liver cancer.
-
Beyond the Snapshot: Continuous physiologic monitoring in clinical trials
Vivalink’s CEO discusses how continuous physiologic monitoring is transitioning from a niche tool for early-stage feasibility studies to a core component of late-stage drug development.
-
Patients open to non-GLP-1 drugs after education, survey finds
A survey finds that while most patients remain unfamiliar with obesity treatments beyond GLP-1s, comprehensive education about alternatives significantly shifts attitudes toward personalized care.
-
ACC26: Amgen’s Repatha cuts first major CV event risk by 31%
New data show Repatha significantly reduces first heart attacks and strokes in high-risk patients without known significant plaque buildup.
-
All you need to know about High-Protein diets
High-protein diets can boost weight loss and muscle gain, but are they right for you? Learn the science, benefits, and key cautions.
-
Best diets for long-term weight management: Evidence-based guide
A practical, research-backed guide to diets that support long-term weight management, focusing on adherence, food quality, protein, and sustainable habits.
-
Winter changes to protect your skin and body from SAD
Discover five expert-recommended changes to safeguard your skin, mood, and overall wellbeing from winter’s harsh effects and Seasonal Affective Disorder (SAD).
-
5 daily habits quietly damaging your hearing — and how to stop them
Many everyday habits, from loud earbuds to skipped ear protection, may be harming your hearing without warning. Learn the risks and simple ways to protect yourself.
Latest posts
-
Navigating the Risks and Rewards of Biomarker-Based Surrogates and Accelerated Approval
The risks and rewards of biomarker-based surrogates are crucial for optimizing clinical trial outcomes and guiding effective treatments.
-
ASH25: Gallop’s LYT-200 shows unprecedented survival in AML
The company’s execs talk about the striking efficacy and safety signals seen in Phase I data, the science behind the molecule, and their vision for transforming AML therapy.
-
Promis reports first human evidence of aβ oligomer reduction by pmn310
PMN310 demonstrates dose-dependent reduction of amyloid-beta oligomers in human CSF, marking a key milestone in Alzheimer’s treatment development.
-
Urologic Health secures $11 million for non-invasive bladder monitoring
Urologic Health raises $11million seed funding to advance a catheter-free bladder monitoring platform toward FDA clearance and US market entry.
-
Novo Nordisk’s denecimig cuts bleeding in hemophilia A regardless of inhibitors
Phase III trial shows once‑monthly and once‑weekly denecimig (Mim8) significantly reduces annualized bleeding rate versus standard care, with up to 95% of patients bleed‑free.